{"id":11352,"date":"2022-07-01T20:34:20","date_gmt":"2022-07-02T00:34:20","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/cri-31st-annual-awards-dinner\/"},"modified":"2022-07-14T15:15:55","modified_gmt":"2022-07-14T19:15:55","slug":"cri-31st-annual-awards-dinner","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/cri-31st-annual-awards-dinner","title":{"rendered":"CRI 31st Annual Awards Dinner"},"content":{"rendered":"

Each year, we honor outstanding individuals whose contributions to cancer research—through scientific discovery or corporate and philanthropic leadership—have significantly advanced our mission to conquer cancer through immunotherapy.<\/p>\n

On Tuesday, November 14, 2017, the Cancer Research Institute will bestow its highest honors on Bill Anderson, Bruce Ratner, Rafi Ahmed, PhD, Thomas F. Gajewski, MD, PhD, and Shannon Turley, PhD, who, like CRI, are dedicated to fueling the development of immunotherapies for all forms of cancer.<\/p>\n

Honoring<\/h2>\n

Bill Anderson<\/strong>
\nChief Executive Officer, Genentech<\/em>
\nReceiving the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research<\/p>\n

Bruce Ratner<\/strong>
\nPhilanthropist and NYC Real Estate Developer<\/em>
\nReceiving the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research<\/p>\n

Rafi Ahmed, PhD<\/strong>
\nDirector, Emory Vaccine Center and Professor of Microbiology and Immunology, Emory University<\/em>
\nReceiving the William B. Coley Award for Distinguished Research in Tumor Immunology<\/p>\n

Thomas F. Gajewski, MD, PhD<\/strong>
\nProfessor, Department of Biology, The University of Chicago<\/em>
\nReceiving the William B. Coley Award for Distinguished Research in Tumor Immunology<\/p>\n

Shannon Turley, PhD<\/strong>
\nPrincipal Scientist, Cancer Immunology, Genentech<\/em>
\nReceiving the Frederick W. Alt Award for New Discoveries in Immunology<\/p>\n

\"CRI<\/a>